Related Experiment Video

Updated: Jun 16, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 29, 2010

Biological/chemopreventive activity of stilbenes and their effect on colon cancer

Agnes M Rimando1, Nanjoo Suh

  • 1United States Department of Agriculture, Agricultural Research Service, Natural Products Utilization Research Unit, University, MS, USA.

Planta Medica
|October 10, 2008
PubMed

Insights

Small fruits contain stilbenes, natural compounds like resveratrol, which show promise in preventing colon cancer. Research explores their mechanisms and effectiveness for cancer chemoprevention.

Area of Science:

  • Nutritional Science
  • Oncology
  • Pharmacology

Background:

  • Colon cancer is a major cause of cancer mortality in Western countries.
  • Dietary intake of fruits and vegetables is associated with reduced colon cancer risk.
  • Small fruits are rich in bioactive stilbenes, including resveratrol and pterostilbene.

Purpose of the Study:

  • To review the potential of stilbenes as colon cancer chemopreventive agents.
  • To summarize their mechanisms of action, pharmacokinetics, and efficacy.
  • To highlight the role of diet and lifestyle in cancer prevention.

Main Methods:

  • Literature review of studies on stilbenes and colon cancer.
  • Analysis of epidemiological data linking fruit/vegetable consumption to cancer risk.
  • Examination of preclinical and clinical data on stilbene efficacy.

Main Results:

  • Stilbenes, such as resveratrol, possess antioxidant, anti-inflammatory, and anti-aging properties.
  • These compounds exhibit diverse pharmacological activities, including cancer prevention.
  • Evidence suggests potential benefits of stilbenes in colon cancer prevention in animal models and humans.

Conclusions:

  • Stilbenes are promising candidates for colon cancer chemoprevention.
  • Further research into their mechanisms and clinical application is warranted.
  • Dietary interventions with stilbene-rich foods may contribute to colon cancer prevention.

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...